Helsinn Healthcare S.A. v. Accord Healthcare Inc.
1:13-cv-02101
Overview
Parties
Defendant
Intas Pharmaceuticals Ltd. Operating Company
Represented By
0 Attorneys ListedAccord Healthcare Inc. Operating Company
Represented By
2 Attorneys ListedDuane Morris LLP
1201 North Market Street, Suite 501
Young, Conaway, Stargatt & Taylor LLP
Rodney Square, 1000 North King Street
Plaintiff
Helsinn Healthcare S.A. NPE (Individual / Inventor)
Represented By
2 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Roche Palo Alto LLC Operating Company
Represented By
2 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 8 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | Asserted | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| π PCT International (WIPO) | PCT World Application | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → |
Accord Healthcare, Inc. v. Helsinn Healthcare S.A. et al.
Patents Involved
There are 2 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US8598218
Liquid pharmaceutical formulations of palonosetron
|
Filed: 2013-05-23
Issued: 2013-12-03
|
Active (6.5 yrs remaining)
Expires: 2033-05-23
|
|
|
US8598219
Liquid pharmaceutical formulations of palonosetron
|
Filed: 2013-05-23
Issued: 2013-12-03
|
Active (6.5 yrs remaining)
Expires: 2033-05-23
|
Patent Enforceability & Injunction Risk Assessment
Active Threat β Patent is within enforceable statutory term; injunctive relief viable.
Standard Statutory Term β No obviousness-type double patenting noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).
Procedural Motions & Interlocutory Orders
Total Motions
7
Dispositive
5
Granted
0
Denied
0
Pending / Review
7
Motions by Category
Key Dispositive Motions & Rulings